Entrada Therapeutics (TRDA) Stock Insights

TRDA price $4.84 +0.43 +9.75%

Ticker
TRDA
Price
$4.84
Change
+0.43 +9.75%
Market cap ?
$188.45M
Beta ?
-0.24
Sector
Healthcare
Industry
Biotechnology

Fair value

TRDA fair value $65.67. Price $4.84. Price is 93% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare TRDA

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—-0.98—2.13M
2026-08-05-1.01-1.05898.00K2.23M
2026-05-07-0.95-1.06875.00K2.92M
2026-02-26-0.94-1.321.30M7.41M
2025-11-06-1.06-1.041.61M8.49M
2025-08-06-1.04-0.861.95M7.83M
2025-05-08-0.42-0.7820.56M9.77M
2025-02-270.03-0.6637.40M13.12M
2024-11-05-0.35-0.6719.57M12.92M
2024-08-131.550.1494.69M12.32M
2024-05-070.68-0.5959.12M14.98M
2024-03-13-0.29-0.0741.85M23.69M
2023-11-071.02-0.7443.73M21.41M
2023-08-08-0.78-0.4318.17M9.78M
2023-05-10-0.21-0.7725.26M9.78M
2023-03-06-0.79-0.84—119.00M
2022-11-07-0.80-0.76——
2022-08-11-0.74-0.72——
2022-05-12-0.69-0.65——
2022-03-15-0.89-1.28——
2021-12-09-9.78-0.87——
2021-11-01-0.48———
2021-03-31-0.41———
2020-12-31-0.42———
2020-09-30-0.34———
2020-06-30-5.18———
2020-03-31-5.18———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-09MPM BIOVENTURES 2018, L.P.Sell28.84K$7.13205.61K
2026-09-09MPM BioVentures 2014, L.P.Sell28.84K$7.13205.61K
2026-09-08MPM BIOVENTURES 2018, L.P.Sell192.50K$7.411.43M
2026-09-08MPM BioVentures 2014, L.P.Sell192.50K$7.411.43M
2026-09-04MPM BIOVENTURES 2018, L.P.Sell38.50K$7.11273.74K
2026-09-04MPM BioVentures 2014, L.P.Sell38.50K$7.11273.74K
2026-09-03MPM BIOVENTURES 2018, L.P.Sell32.26K$7.17231.33K
2026-09-03MPM BioVentures 2014, L.P.Sell32.26K$7.17231.33K
2026-09-02MPM BIOVENTURES 2018, L.P.Sell25.13K$7.19180.69K
2026-09-02MPM BioVentures 2014, L.P.Sell25.13K$7.19180.69K
2026-09-02Doshi DipalSell8.72K$7.1462.32K
2026-09-02Dowden Nathan JSell2.53K$7.1418.06K
2026-09-02Sethuraman NatarajanSell2.08K$7.1414.85K
2026-09-02WENTWORTH KORY JAMESSell1.73K$7.1412.38K
2026-09-01MPM BIOVENTURES 2018, L.P.Sell29.09K$7.06205.36K
2026-09-01MPM BioVentures 2014, L.P.Sell29.09K$7.06205.36K
2026-08-31MPM BIOVENTURES 2018, L.P.Sell44.26K$6.99309.37K
2026-08-31MPM BioVentures 2014, L.P.Sell44.26K$6.99309.37K
2026-08-28MPM BIOVENTURES 2018, L.P.Sell3.73K$7.0126.17K
2026-08-28MPM BioVentures 2014, L.P.Sell3.73K$7.0126.17K
2026-08-27MPM BIOVENTURES 2018, L.P.Sell38.92K$7.20280.24K
2026-08-27MPM BioVentures 2014, L.P.Sell38.92K$7.20280.24K
2026-08-26MPM BioVentures 2014, L.P.Sell14.57K$7.06102.86K
2026-08-26MPM BIOVENTURES 2018, L.P.Sell14.57K$7.06102.86K
2026-08-25MPM BioVentures 2014, L.P.Sell26.52K$7.54199.98K
2026-08-25MPM BIOVENTURES 2018, L.P.Sell26.52K$7.54199.98K
2026-08-24MPM BioVentures 2014, L.P.Sell21.62K$7.34158.71K
2026-08-24MPM BIOVENTURES 2018, L.P.Sell21.62K$7.34158.71K
2026-08-10PARMAR KUSHSell92.44K$7.00647.11K
2026-08-07PARMAR KUSHSell52.32K$6.85358.37K
2026-08-075AM Ventures V, L.P.Sell52.32K$6.85358.37K
2026-08-06PARMAR KUSHSell10.49K$7.0073.46K
2026-08-065AM Ventures V, L.P.Sell10.49K$7.0073.46K
2026-07-315AM Ventures V, L.P.Sell1.72K$6.8511.77K
2026-07-31PARMAR KUSHSell1.72K$6.8511.77K
2026-07-305AM Ventures V, L.P.Sell114.76K$6.93795.26K
2026-07-30PARMAR KUSHSell114.76K$6.93795.26K
2026-06-10PARMAR KUSHBuy19.00K$5.97113.43K
2026-06-10KIM PETER SBuy19.00K$5.97113.43K
2026-06-10Chapman GinaBuy19.00K$5.97113.43K
2026-06-10Radhakrishnan MahaBuy19.00K$5.97113.43K
2026-06-10Thistle MaryBuy19.00K$5.97113.43K
2026-06-10Zeiher Bernhardt GBuy19.00K$5.97113.43K
2026-05-20Zeiher Bernhardt GBuy5.00K$5.8629.32K
2026-05-04Sethuraman NatarajanSell25.91K$15.39398.81K
2026-05-04Dowden Nathan JBuy15.00K$1.7426.10K
2026-05-04Dowden Nathan JSell15.00K$15.33229.95K
2026-05-04Dowden Nathan JSell15.00K$1.7426.10K
2026-04-01WENTWORTH KORY JAMESSell2.50K$12.9532.38K
2026-03-10Dowden Nathan JSell11.89K$13.05155.19K
2026-03-10WENTWORTH KORY JAMESSell11.39K$13.02148.22K
2026-03-09Dowden Nathan JSell3.12K$13.0240.58K
2026-03-09WENTWORTH KORY JAMESSell5.09K$13.0066.16K
2026-03-04WENTWORTH KORY JAMESSell7.99K$12.2597.89K
2026-03-03Doshi DipalSell19.18K$11.76225.50K
2026-03-03WENTWORTH KORY JAMESSell5.71K$11.7667.15K
2026-03-03Dowden Nathan JSell14.04K$11.76165.04K
2026-03-03Sethuraman NatarajanSell7.58K$11.7689.08K
2026-03-02Doshi DipalSell9.87K$11.66115.05K
2026-03-02WENTWORTH KORY JAMESSell2.94K$11.6634.26K
2026-03-02Dowden Nathan JSell7.22K$11.6684.21K
2026-03-02Sethuraman NatarajanSell3.90K$11.6645.44K
2026-03-01Doshi DipalBuy139.40K——
2026-03-01Doshi DipalBuy208.00K$11.932.48M
2026-03-01WENTWORTH KORY JAMESBuy44.60K——
2026-03-01WENTWORTH KORY JAMESBuy66.60K$11.93794.54K
2026-03-01Dowden Nathan JBuy55.80K——
2026-03-01Dowden Nathan JBuy83.20K$11.93992.58K
2026-03-01Sethuraman NatarajanBuy55.80K——
2026-03-01Sethuraman NatarajanBuy83.20K$11.93992.58K
2025-11-21WENTWORTH KORY JAMESSell8.91K$9.9888.93K
2025-11-20BAKER BROS. ADVISORS LPBuy13.08K$9.07118.69K
2025-11-20BAKER BROS. ADVISORS LPBuy13.39K$9.07121.39K
2025-11-20BAKER BROS. ADVISORS LPBuy1.19K$9.0710.76K
2025-11-20BAKER BROS. ADVISORS LPBuy1.21K$9.0711.00K
2025-11-14PARMAR KUSHSell200.00K$8.801.76M
2025-11-145AM Ventures V, L.P.Sell200.00K$8.801.76M
2025-11-12BAKER BROS. ADVISORS LPBuy11.49K$7.9591.43K
2025-11-12BAKER BROS. ADVISORS LPBuy80.88K$7.73625.33K
2025-11-12BAKER BROS. ADVISORS LPBuy1.04K$7.958.27K
2025-11-12BAKER BROS. ADVISORS LPBuy7.32K$7.7356.60K
2025-11-11BAKER BROS. ADVISORS LPBuy30.88K$7.54232.81K
2025-11-11BAKER BROS. ADVISORS LPBuy11.70K$7.3986.48K
2025-11-11BAKER BROS. ADVISORS LPBuy2.79K$7.5421.07K
2025-11-11BAKER BROS. ADVISORS LPBuy1.06K$7.397.83K
2025-11-10BAKER BROS. ADVISORS LPBuy2.95K$7.2221.29K
2025-11-10BAKER BROS. ADVISORS LPBuy25.36K$7.21182.97K
2025-11-10BAKER BROS. ADVISORS LPBuy267$7.221.93K
2025-11-10BAKER BROS. ADVISORS LPBuy2.30K$7.2116.56K
2025-09-02Doshi DipalSell8.72K$5.4347.37K
2025-09-02Dowden Nathan JSell1.75K$5.439.48K
2025-09-02Sethuraman NatarajanSell1.76K$5.439.56K
2025-09-02WENTWORTH KORY JAMESSell1.73K$5.439.42K
2025-07-09PARMAR KUSHSell20.07K$7.50150.53K
2025-07-09PARMAR KUSHSell6.93K$7.5052.03K
2025-07-095AM Ventures V, L.P.Sell20.07K$7.50150.53K
2025-07-095AM Ventures V, L.P.Sell6.93K$7.5052.03K
2025-07-01PARMAR KUSHSell18.58K$7.12132.32K
2025-07-01PARMAR KUSHSell6.42K$7.1245.74K
2025-07-015AM Ventures V, L.P.Sell18.58K$7.12132.32K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 130, holders +11 vs prior quarter. Ownership 69.35%.

HolderSharesChangeChange %Value
BAKER BROS. ADVISORS LP5.07M00.00%37.34M
5AM VENTURE MANAGEMENT, LLC4.06M00.00%29.85M
BLACKROCK, INC.2.58M224.54K+9.52%19.01M
MERCK & CO., INC.1.74M1.74MNew12.80M
VANGUARD CAPITAL MANAGEMENT LLC1.27M13.62K+1.08%9.34M
MPM BIOIMPACT LLC1.25M1.25MNew9.22M
TCG CROSSOVER MANAGEMENT, LLC1.06M-1.23M-53.65%7.80M
WELLINGTON MANAGEMENT GROUP LLP954.42K-80.36K-7.77%7.02M
MILLENNIUM MANAGEMENT LLC763.96K244.60K+47.10%5.62M
STEPSTONE GROUP LP761.28K00.00%5.60M
GEODE CAPITAL MANAGEMENT, LLC717.43K50.08K+7.50%5.28M
AQR CAPITAL MANAGEMENT LLC699.54K620.04K+780.00%5.15M
STATE STREET CORP596.68K62.88K+11.78%4.39M
PRICE T ROWE ASSOCIATES INC /MD/542.32K16.27K+3.09%3.99M
JPMORGAN CHASE & CO496.46K481.61K+3243.82%3.83M
ACADIAN ASSET MANAGEMENT LLC400.86K67.69K+20.32%2.94M
CITADEL ADVISORS LLC394.32K179.31K+83.39%2.90M
DIMENSIONAL FUND ADVISORS LP376.14K51.66K+15.92%2.77M
NORTHERN TRUST CORP309.94K74.95K+31.89%2.28M
JACOBS LEVY EQUITY MANAGEMENT, INC303.46K-30.45K-9.12%2.23M
NANTAHALA CAPITAL MANAGEMENT, LLC300.57K141.24K+88.65%2.21M
VANGUARD PORTFOLIO MANAGEMENT LLC254.13K33.64K+15.25%1.87M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC197.14K-17.61K-8.20%1.45M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.197.14K197.14KNew1.45M
LONGAEVA PARTNERS L.P.195.24K-9.74K-4.75%1.44M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Entrada Therapeutics (TRDA) Stock Insights

TRDA$4.84+0.43 +9.75%

$188.45M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History